Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to ARQT Stock Lookup

(ARQT) – Hot Corp. News

Nov 15, 2022 08:01 AM Arcutis Biotherapeutics (ARQT) Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis in Adults and Children Aged Six Years and Older Met Its Primary Endpoint

Back to ARQT Stock Lookup